Evidence map›Paper›PMID 19376777›Full record

ArticleThe Journal of biological chemistry2009

The external aldimine form of serine palmitoyltransferase: structural, kinetic, and spectroscopic analysis of the wild-type enzyme and HSAN1 mutant mimics.

Marine C C Raman, Kenneth A Johnson, Beverley A Yard, Jonathan Lowther, Lester G Carter, James H Naismith, Dominic J Campopiano

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 67 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Marine C C RamanFrom EaStChem, School of Chemistry, University of Edinburgh, Edinburgh EH9 3JJ.
Kenneth A JohnsonEaStChem, Scottish Structural Proteomics Facility, and Centre for Biomolecular Science, University of St. Andrews, Edinburgh KY16 9RH, Scotland, United Kingdom.
Beverley A YardFrom EaStChem, School of Chemistry, University of Edinburgh, Edinburgh EH9 3JJ.
Jonathan LowtherFrom EaStChem, School of Chemistry, University of Edinburgh, Edinburgh EH9 3JJ.
Lester G CarterEaStChem, Scottish Structural Proteomics Facility, and Centre for Biomolecular Science, University of St. Andrews, Edinburgh KY16 9RH, Scotland, United Kingdom.
James H NaismithEaStChem, Scottish Structural Proteomics Facility, and Centre for Biomolecular Science, University of St. Andrews, Edinburgh KY16 9RH, Scotland, United Kingdom. Electronic address: naismith@st-andrews.ac.uk.
Dominic J CampopianoFrom EaStChem, School of Chemistry, University of Edinburgh, Edinburgh EH9 3JJ. Electronic address: Dominic.Campopiano@ed.ac.uk.
University of Edinburgh · GBUniversity of St Andrews · GB

Funding

Biotechnology and Biological Sciences Research Council BB/F008503/1Biotechnology and Biological Sciences Research Council BB/F009739/1Biotechnology and Biological Sciences Research Council BBS/B/14434Medical Research Council G0500367
6 · The paper itself

Abstract

Sphingolipid biosynthesis begins with the condensation of L-serine and palmitoyl-CoA catalyzed by the PLP-dependent enzyme serine palmitoyltransferase (SPT). Mutations in human SPT cause hereditary sensory autonomic neuropathy type 1, a disease characterized by loss of feeling in extremities and severe pain. The human enzyme is a membrane-bound hetereodimer, and the most common mutations are located in the enzymatically incompetent monomer, suggesting a "dominant" or regulatory effect. The molecular basis of how these mutations perturb SPT activity is subtle and is not simply loss of activity. To further explore the structure and mechanism of SPT, we have studied the homodimeric bacterial enzyme from Sphingomonas paucimobilis. We have analyzed two mutants (N100Y and N100W) engineered to mimic the mutations seen in hereditary sensory autonomic neuropathy type 1 as well as a third mutant N100C designed to mimic the wild-type human SPT. The N100C mutant appears fully active, whereas both N100Y and N100W are significantly compromised. The structures of the holoenzymes reveal differences around the active site and in neighboring secondary structure that transmit across the dimeric interface in both N100Y and N100W. Comparison of the l-Ser external aldimine structures of both native and N100Y reveals significant differences that hinder the movement of a catalytically important Arg(378) residue into the active site. Spectroscopic analysis confirms that both N100Y and N100W mutants subtly affect the chemistry of the PLP. Furthermore, the N100Y and R378A mutants appear less able to stabilize a quinonoid intermediate. These data provide the first experimental insight into how the most common disease-associated mutations of human SPT may lead to perturbation of enzyme activity.

Indexed as

Amino Acid SubstitutionBase SequenceCatalytic DomainCrystallography, X-RayDNA PrimersHereditary Sensory and Autonomic NeuropathiesHumansIminesKineticsModels, BiologicalModels, MolecularMolecular MimicryMutagenesis, Site-DirectedProtein ConformationRecombinant ProteinsSerine C-PalmitoyltransferaseDNA PrimersIminesRecombinant ProteinsSerine C-Palmitoyltransferase

Identifiers

PMID19376777
PMCPMC2719368
OpenAlexW1968436575

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.